{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:51:47Z","timestamp":1767703907884,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-023-01661-2","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T08:02:16Z","timestamp":1697702536000},"page":"1093-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elevated liver fibrosis-4 index predicts recurrence after catheter ablation for atrial fibrillation in patients with heart failure"],"prefix":"10.1007","volume":"67","author":[{"given":"Tomoya","family":"Iwawaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1444-090X","authenticated-orcid":false,"given":"Itsuro","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Shimojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuya","family":"Inden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"1661_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2022.12.013","author":"A Cordero","year":"2023","unstructured":"Cordero A, Escribano D, Quintanilla MA, L\u00f3pez-Ayala JM, Masi\u00e1 MD, Cazorla D, et al. Prognostic value of liver fibrosis assessed by the FIB-4 index in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2023. https:\/\/doi.org\/10.1016\/j.rec.2022.12.013.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"1661_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ehf2.13222","volume":"8","author":"R Itier","year":"2021","unstructured":"Itier R, Guillaume M, Ricci JE, Roubille F, Delarche N, Picard F, et al. Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues. ESC Heart Fail. 2021;8(2):789\u201398. https:\/\/doi.org\/10.1002\/ehf2.13222.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"1661_CR3","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/ehf2.14087","volume":"9","author":"X Liu","year":"2022","unstructured":"Liu X, Chen W, Shao W, Jiang Y, Cao Z, He W, et al. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction. ESC Heart Fail. 2022;9(6):3985\u201394. https:\/\/doi.org\/10.1002\/ehf2.14087.","journal-title":"ESC Heart Fail"},{"key":"1661_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-023-02273-6","author":"D Maeda","year":"2023","unstructured":"Maeda D, Kanzaki Y, Sakane K, Tsuda K, Akamatsu K, Hourai R, et al. Prognostic impact of a reduction in the fibrosis-4 index among patients hospitalized with acute heart failure. Heart Vessels. 2023. https:\/\/doi.org\/10.1007\/s00380-023-02273-6.","journal-title":"Heart Vessels"},{"issue":"11","key":"1661_CR5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1253\/circj.CJ-22-0109","volume":"86","author":"M Nakashima","year":"2022","unstructured":"Nakashima M, Tanakaya M, Miyoshi T, Saito T, Katayama Y, Sakuragi S, et al. The fibrosis-4 index predicts cardiovascular prognosis in patients with severe isolated tricuspid regurgitation. Circ J. 2022;86(11):1777\u201384. https:\/\/doi.org\/10.1253\/circj.CJ-22-0109.","journal-title":"Circ J"},{"issue":"3","key":"1661_CR6","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/ehf2.13317","volume":"8","author":"M Nakashima","year":"2021","unstructured":"Nakashima M, Sakuragi S, Miyoshi T, Takayama S, Kawaguchi T, Kodera N, et al. Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction. ESC Heart Fail. 2021;8(3):2240\u20137. https:\/\/doi.org\/10.1002\/ehf2.13317.","journal-title":"ESC Heart Fail"},{"key":"1661_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijcard.2020.09.056","volume":"324","author":"N Shibata","year":"2021","unstructured":"Shibata N, Kondo T, Kazama S, Kimura Y, Oishi H, Arao Y, et al. Impact of predictive value of fibrosis-4 index in patients hospitalized for acute heart failure. Int J Cardiol. 2021;324:90\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.056.","journal-title":"Int J Cardiol"},{"issue":"12","key":"1661_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13856","volume":"52","author":"CH Tseng","year":"2022","unstructured":"Tseng CH, Huang WM, Yu WC, Cheng HM, Chang HC, Hsu PF, et al. The fibrosis-4 score is associated with long-term mortality in different phenotypes of acute heart failure. Eur J Clin Invest. 2022;52(12): e13856. https:\/\/doi.org\/10.1111\/eci.13856.","journal-title":"Eur J Clin Invest"},{"key":"1661_CR9","doi-asserted-by":"publisher","unstructured":"Vallet-Pichard A, Mallet V, Pol S. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. Hepatology (Baltimore, Md). 2006;44(3):769; author reply -70. https:\/\/doi.org\/10.1002\/hep.21334.","DOI":"10.1002\/hep.21334"},{"key":"1661_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.960259","volume":"9","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang Y, Luo F, Zhai Y, Li J, Chen Y, et al. Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients. Front Cardiovasc Med. 2022;9: 960259. https:\/\/doi.org\/10.3389\/fcvm.2022.960259.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"1661_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/joa3.12491","volume":"37","author":"A Nogami","year":"2021","unstructured":"Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. J Arrhythm. 2021;37(4):709\u2013870. https:\/\/doi.org\/10.1002\/joa3.12491.","journal-title":"J Arrhythm"},{"issue":"10","key":"1661_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312. https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1661_CR13","doi-asserted-by":"publisher","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891\u2013975. https:\/\/doi.org\/10.1002\/ejhf.592.","DOI":"10.1002\/ejhf.592"},{"issue":"4","key":"1661_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jchf.2016.11.015","volume":"5","author":"IS Anand","year":"2017","unstructured":"Anand IS, Claggett B, Liu J, Shah AM, Rector TS, Shah SJ, et al. Interaction between spironolactone and natriuretic peptides in patients with heart failure and preserved ejection fraction: from the TOPCAT trial. JACC Heart Fail. 2017;5(4):241\u201352. https:\/\/doi.org\/10.1016\/j.jchf.2016.11.015.","journal-title":"JACC Heart Fail"},{"key":"1661_CR15","doi-asserted-by":"publisher","unstructured":"Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J. 2014;78(8):1997\u20132021. https:\/\/doi.org\/10.1253\/circj.cj-66-0092.","DOI":"10.1253\/circj.cj-66-0092"},{"issue":"38","key":"1661_CR16","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210.","journal-title":"Eur Heart J"},{"issue":"11","key":"1661_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.hrthm.2020.06.020","volume":"17","author":"WW Su","year":"2020","unstructured":"Su WW, Reddy VY, Bhasin K, Champagne J, Sangrigoli RM, Braegelmann KM, et al. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: results from the multicenter STOP Persistent AF trial. Heart Rhythm. 2020;17(11):1841\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2020.06.020.","journal-title":"Heart Rhythm"},{"issue":"7","key":"1661_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/jce.15965","volume":"34","author":"P Mililis","year":"2023","unstructured":"Mililis P, Kariki O, Saplaouras A, Bazoukis G, Dragasis S, Patsiotis IG, et al. Radiofrequency versus cryoballoon catheter ablation in patients with persistent atrial fibrillation: a randomized trial. J Cardiovasc Electrophysiol. 2023;34(7):1523\u20138. https:\/\/doi.org\/10.1111\/jce.15965.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"13","key":"1661_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.015927","volume":"9","author":"M Masuda","year":"2020","unstructured":"Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, et al. Additional low-voltage-area ablation in patients with paroxysmal atrial fibrillation: results of the randomized controlled VOLCANO trial. J Am Heart Assoc. 2020;9(13): e015927. https:\/\/doi.org\/10.1161\/jaha.120.015927.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"1661_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.009158","volume":"7","author":"I Morishima","year":"2018","unstructured":"Morishima I, Okumura K, Morita Y, Kanzaki Y, Takagi K, Yoshida R, et al. High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation of atrial fibrillation. J Am Heart Assoc. 2018;7(14): e02707. https:\/\/doi.org\/10.1161\/jaha.118.009158.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"1661_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/eurheartj\/ehv501","volume":"37","author":"K Kaitani","year":"2016","unstructured":"Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, et al. Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial. Eur Heart J. 2016;37(7):610\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv501.","journal-title":"Eur Heart J"},{"key":"1661_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.957245","volume":"13","author":"R Decoin","year":"2022","unstructured":"Decoin R, Butruille L, Defrancq T, Robert J, Destrait N, Coisne A, et al. High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation. Front Endocrinol. 2022;13: 957245. https:\/\/doi.org\/10.3389\/fendo.2022.957245.","journal-title":"Front Endocrinol"},{"key":"1661_CR23","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3389\/fphar.2019.01420","volume":"10","author":"R Coppini","year":"2019","unstructured":"Coppini R, Santini L, Palandri C, Sartiani L, Cerbai E, Raimondi L. Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation. Front Pharmacol. 2019;10:1420. https:\/\/doi.org\/10.3389\/fphar.2019.01420.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1661_CR24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1165","volume":"9","author":"MA Mangi","year":"2017","unstructured":"Mangi MA, Rehman H, Minhas AM, Rafique M, Bansal V, Constantin J. Non-Alcoholic fatty liver disease association with cardiac arrhythmias. Cureus. 2017;9(4): e1165. https:\/\/doi.org\/10.7759\/cureus.1165.","journal-title":"Cureus"},{"issue":"15","key":"1661_CR25","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/eurheartj\/ehs079","volume":"33","author":"S Nattel","year":"2012","unstructured":"Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J. 2012;33(15):1870\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehs079.","journal-title":"Eur Heart J"},{"key":"1661_CR26","doi-asserted-by":"publisher","unstructured":"Cosio FG, Palacios J, Vidal JM, Cocina EG, G\u00f3mez-S\u00e1nchez MA, Tamargo L. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol. 1983;51(1):122\u201330. https:\/\/doi.org\/10.1016\/s0002-9149(83)80022-8.","DOI":"10.1016\/s0002-9149(83)80022-8"},{"issue":"7","key":"1661_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0002-9149(84)80203-9","volume":"54","author":"AE Buxton","year":"1984","unstructured":"Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol. 1984;54(7):755\u201361. https:\/\/doi.org\/10.1016\/s0002-9149(84)80203-9.","journal-title":"Am J Cardiol"},{"issue":"9","key":"1661_CR28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/circresaha.114.303772","volume":"114","author":"PS Chen","year":"2014","unstructured":"Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500\u201315. https:\/\/doi.org\/10.1161\/circresaha.114.303772.","journal-title":"Circ Res"},{"issue":"8","key":"1661_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00535-016-1304-z","volume":"52","author":"T Nishio","year":"2017","unstructured":"Nishio T, Taura K, Iwaisako K, Koyama Y, Tanabe K, Yamamoto G, et al. Hepatic vagus nerve regulates Kupffer cell activation via \u03b17 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis. J Gastroenterol. 2017;52(8):965\u201376. https:\/\/doi.org\/10.1007\/s00535-016-1304-z.","journal-title":"J Gastroenterol"},{"issue":"6a","key":"1661_CR30","doi-asserted-by":"publisher","first-page":"2d","DOI":"10.1016\/s0002-9149(02)03373-8","volume":"91","author":"WH Maisel","year":"2003","unstructured":"Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6a):2d\u20138d. https:\/\/doi.org\/10.1016\/s0002-9149(02)03373-8.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1661_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/s0008-6363(99)00017-6","volume":"42","author":"GF Tomaselli","year":"1999","unstructured":"Tomaselli GF, Marb\u00e1n E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42(2):270\u201383. https:\/\/doi.org\/10.1016\/s0008-6363(99)00017-6.","journal-title":"Cardiovasc Res"},{"issue":"48","key":"1661_CR32","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","volume":"35","author":"V Melenovsky","year":"2014","unstructured":"Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014;35(48):3452\u201362. https:\/\/doi.org\/10.1093\/eurheartj\/ehu193.","journal-title":"Eur Heart J"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-023-01661-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T09:20:38Z","timestamp":1722331238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-023-01661-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s10840-023-01661-2","relation":{},"ISSN":["1572-8595"],"issn-type":[{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local institutional ethics committee of the Ogaki Municipal Hospital. All patients provided written informed consent before the procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}